You are here

Susan M. Schneider, PhD, RN, AOCN, ACNS-BC, FAAN

Associate Professor
(919) 684-9240
3051 Pearson Building

Representative Publications

  • 2007 -- PubMed # : 17562631 Schneider, S. M. and Hood, L. E. Virtual reality: a distraction intervention for chemotherapy. Oncol Nurs Forum. 34(1); 39-46 PMC2121303
  • 2005 -- PubMed # : 16355560 Rowe, K. and Schneider, S. Profile of cancer-related symptoms prior to chemotherapy. J Support Oncol. Nov.-Dec., 2005 3(6 Suppl 4); 32-33
  • 2005 -- PubMed # : 14722591 Schneider, S. M. and Prince-Paul, M. and Allen, M. J. and Silverman, P. and Talaba, D. Virtual reality as a distraction intervention for women receiving chemotherapy. Oncol Nurs Forum. 31(1); 81-8
  • 2005 -- PubMed # : 16330971 Penne, K. and Bolin, C. and Schneider, S. and Allen, D. Gefitinib (Iressa, ZD1839) and tyrosine kinase inhibitors: The wave of the future in cancer therapy. Cancer Nurs. February, 2005 28(6); 481-486
  • 2005 -- Schneider, S. M. Using virtual reality as a distraction intervention to mitigate chemotherapy symptoms. In Human-Computer Interaction: Theory and Practice edited by Jacko, J. & Stephanidis, C.. 2005; : L.A. Erlbaum. 2005
  • 2004 -- Schneider, S. M. Chemotherapy distraction. In Virtual Healing edited by Weiderhold, B.. 2004; : Interactive Media Institute. 2004
  • 2003 -- PubMed # : 12855087 Schneider, S. M. and Ellis, M. and Coombs, W. T. and Shonkwiler, E. L. and Folsom, L. C. Virtual reality intervention for older women with breast cancer. Cyberpsychol Behav. 6(3); 301-7
  • 2003 -- PubMed # : 14656195 Visovsky, C. and Schneider, S. M. Cancer-related fatigue. Online J Issues Nurs. 8(3); 8
  • 2002 -- PubMed # : 11889684 Bender, C. M. and McDaniel, R. W. and Murphy-Ende, K. and Pickett, M. and Rittenberg, C. N. and Rogers, M. P. and Schneider, S. M. and Schwartz, R. N. Chemotherapy-induced nausea and vomiting. Clin J Oncol Nurs. 6(2); 94-102
  • 2002 -- Schneider, S. M. Infection. The Spectrum. 2002 1


Friday, March 27, 2015

Susan Schneider, PhD, RN, AOCN, FAAN, associate professor and faculty lead for the graduate oncology specialty at the Duke University School of Nursing, was elected President-elect of the Oncology Nursing Society (ONS). Schneider will assume the role of President of the 35,000 member national society for a two-year term beginning in 2016, following a year as President-elect.

Monday, March 9, 2015

Sue Schneider has been elected as the President-Elect of the Oncology Nursing Society (ONS) by the ONS board of directors. ONS is a 35,000-member professional association committed to promoting excellence in oncology nursing and the transformation of cancer care. Sue will assume this position the end of April.

Friday, February 13, 2015

Susan Schneider will be the keynote speaker for the 4th annual Kosonen Nursing Summit on April 21, 2015, at Levine Cancer Center in Charlotte, N.C. The title of her talk is "Anticipation and Conjecture: What the Future Holds for Oncology Nursing."

Thursday, September 11, 2014

Susan Schneider presented "Implementing NCCN® Guidelines into Practice" at the 18th International Conference on Cancer Nursing (ICCN) in Panama City, Panama.

Monday, June 16, 2014

Sue Schneider published an article entitled "A nurse coaching intervention to empower oral chemotherapy adherence" in the Journal of the Advanced Practitioner in Oncology.

Friday, June 6, 2014

Five DUSON Oncology students this year received nearly one third of the Graduate Scholarships in Cancer Nurse Practice awarded by the American Cancer Society (ACS). In addition, two students who received ACS scholarships last year, were awarded a second year of renewed funding for their education.

Tuesday, April 8, 2014

Susan Schneider authored a chapter entitled "Strategies to improve adherence to oral chemotherapy" that has been published in the Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook, 3rd edition.

Tuesday, November 26, 2013

Kathy Trotter, Susan Schneider and Barbara Turner have a paper entitled "Group appointments in a breast cancer survivorship clinic" that has been published in the Journal of the Advanced Practitioner in Oncology.

Friday, October 19, 2012

Susan Schneider and team submitted an NIH R01 application entitled "Promoting Oral Chemotherapy Adherence with MobileRN" requesting funding for a three-year period with a start date of July 1, 2013.